Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on June 18, 2009

Arteriosclerosis, Thrombosis, and Vascular Biology. 2009
Published online before print June 18, 2009, doi: 10.1161/ATVBAHA.109.184713
A more recent version of this article appeared on October 1, 2009
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
29/10/1537    most recent
ATVBAHA.109.184713v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wu, B. J.
Right arrow Articles by Stocker, R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, B. J.
Right arrow Articles by Stocker, R.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CARBON MONOXIDE
Medline Plus Health Information
*Stem Cells

Submitted on January 18, 2009
Accepted on May 28, 2009

Heme Oxygenase-1 Increases Endothelial Progenitor Cells

Ben J. Wu ; Robyn G. Midwinter ; Carlos Cassano ; Konstanze Beck ; Yutang Wang ; Dechaboon Changsiri ; Jennifer R. Gamble ; and Roland Stocker *

From the Centre for Vascular Research, Bosch Institute and Discipline of Pathology, School of Medical Sciences, Faculty of Medicine (B.J.W., R.G.M., K.B., Y.W., D.C., R.S.), and the Centenary Institute of Cancer Medicine and Cell Biology (C.C., J.R.G.), University of Sydney, Australia.

* To whom correspondence should be addressed. E-mail: rstocker{at}med.usyd.edu.au.

Objectives—Induction of heme oxygenase-1 (HO-1) protects against atherosclerotic disease in part by promoting reendothelialization. As endothelial progenitor cells (EPCs) contribute to reendothelialization, we examined the role of HO-1 on bone marrow and circulating EPCs.

Methods and Results—In a rabbit model of aortic balloon injury, pharmacological induction of HO-1 enhanced reendothelialization at sites with and without adjacent blood vessels, the latter indicative of a contribution by EPCs. Coinciding with maximal HO-1 induction in the injured vessel, plasma concentrations of bilirubin and the numbers of circulating progenitor cells were elevated. Both processes were abolished by cotreatment of the animals with an inhibitor of HO-1. Inducers of HO-1 promoted bone marrow cells to form progenitor cell colonies, and Flk1+/Sca-1+-cells to adhere to the luminal surface of the injured vessel. In noninjured mice, HO-1 inducers also increased bone marrow and circulating EPCs, and the ability of these cells to differentiate and form colonies. Compared to wild-type mice, bone marrow cells from HO-1-/- mice generated fewer endothelial colony-forming cells, and HO-1 inducers failed to promote CFU-Hill colony formation.

Conclusions—These findings suggest that HO-1 contributes to vascular repair by increasing circulating EPCs derived from the bone marrow.


Key words: bilirubin • carbon monoxide • endothelial cells • succinobucol • vascular injury